Research Progress on Immunopathological Mechanisms of Graft Arteriosclerosis

Home > Archive>Volume 24, Issue 6, 2016 >639-643

Research Progress on Immunopathological Mechanisms of Graft Arteriosclerosis
DOI:
                        
                    
CSTR:
                        
                    
Author:
                        ZHAO Xiao-XiaZHAO Xiao-Xia
Department of Clinical Laboratory, Tianjin Fourth Central Hospital, Tianjin 300143, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site

                    
Affiliation:Department of Clinical Laboratory, Tianjin Fourth Central Hospital, Tianjin 300143, China)
Clc Number:R392.4
Fund Project:

Article

Figures

Metrics

Reference [35]

Cited by

Materials

Comments

Abstract:

Immune response of the allograft artery, especially the immune injury of vascular endothelial cells and smooth muscle cells, can cause the occurrence of graft arteriosclerosis. Effects of T cells, cytokines and antibodies on graft artery are to induce the vascular cell injury and phenotype change, and to lead graft vascular intimal thickening and vascular dilation contraction dysfunction. This paper mainly introduces the immunopathological mechanisms of graft arteriosclerosis.

Key words:Graft Arteriosclerosis; Immunopathological Mechanism; Vascular Cell Phenotype

Reference

[1] Castellani C, Angelini A, de Boer OJ, et al.Intraplaque hemorrhage in cardiac allograft vasculopathy.Am J Transplant, 4,4(1):184-192.

[2] Anderson TJ, Meredith IT, Uehata A, et al.Functional significance of intimal thickening as detected by intravascular ultrasound early and late after cardiac transplantation.Circulation, 3,8(3):1 093-100.

[3] Ferns GA, Raines EW, Sprugel KH, et al.Inhibition of neointimal smooth muscle accumulation after angioplasty by anantibody to PDGF.Science, 1,3(5024):1 129-132.

[4] Soule ZM, Pilon EA, Dieude M, et al.The perlecan fragment LG3 is a novel regulator of obliterative remodeling associated with allograft vascular rejection.Circ Res, 2,0(1):94-104.

[5] Shi C, Lee WS, He Q, et al.Immunologic basis of transplant-associated arteriosclerosis.Proc Natl Acad Sci USA, 6,3(9):4 051-056.

[6] Russell PS, Chase CM, Winn HJ, et al.Coronary atherosclerosis in transplanted mouse hearts:II.importance of humoral immunity.J Immunol, 4,2(10):5 135-141.

[7] Dong C, Wilson JE, Winters GL, et al.Human transplant coronary artery disease:pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy.Lab Invest, 6,4(5):921-931.

[8] Choy JC, McDonald PC, Suarez AC, et al.Granzyme bina the rosclerosisand transplant vascular disease:association with cell death and atherosclerotic disease severity.Mod Pathol, 3,6(5):460-470.

[9] Lai JC, Tranfield EM, Walker DC, et al.Ultrastructural evidence of early endothelial damage incoronary arteries of ratcardiac allografts.J Heart Lung Transplant, 3,2(9):993-1 004.

[10] Choy JC, KerjnerA, Wong BW, et al.Perforin mediates endothelial cell death and resultant transplant vascular disease in cardiac allografts.Am J Pathol, 4,5(1):127-133.

[11] Schnickel GT, Whiting D, Hsieh GR, et al.CD8 lymphocytes are sufficient for the development of chronic rejection.Transplantation, 4,8(11):1 634-639.

[12] Clarke MC, Figg N, Maguire JJ, et al.Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis.Nat Med, 6,2(9):1 075-080.

[13] Yu H, Clarke MC, Figg N, et al.Smooth muscle cell apoptosis promotes vessel remodeling and repairvia activation of cell migration, proliferation, and collagen synthesis.Arterioscler Thromb Vasc Biol, 1,1(11):2 402-409.

[14] Legare JF, Issekutz T, Lee TD, et al.CD8＋T lymphocytes mediate destruction of the vascular mediaina model of chronic rejection.Am J Pathol, 0,7(3):859-865.

[15] Hart-Matyas M, Nejat S, Jordan JL, et al.IFN-gamma and Fas/FasL pathways cooperate to induce medial cell loss and neointimal lesion formation in allograft vasculopathy.Transpl Immunol, 0,2(3-4):157-164.

[16] Li J, Liu S, Li W, et al.Vascular smooth muscle cell apoptosis promotes transplant arteriosclerosis through inducing the production of SDF-1α.Am J Transplant, 2,2(8):2 029-043.

[17] 朱国超, 陈知水, 董冲, 等.染料木黄酮防治大鼠移植动脉硬化的实验研究.中国现代医学杂志, 6,6(15):2 294-297.

[18] Sims GP, Rowe DC, Rietdijk ST, et al.HMGB1 and RAGE in inflammation and cancer.Annu Rev Immunol, 0,8:367-388.

[19] Rao DA, Tracey KJ, Pober JS.IL-1 alpha and IL-1 beta are endogenous mediators linking cell injury to the adaptive alloimmune response.J Immunol, 7,9(10):6 536-546.

[20] Zou H, Yang Y, Gao M, et al.HMGB1 is involved in chronic rejection of cardiac allograft via promoting in flammatory-like mDCs.Am J Transplant, 4,4(8):1 765-777.

[21] Ahmad U, Ali R, Lebastchi AH, et al.IFN-gamma primes intact human coronary arteries and cultured coronary smooth muscle cells to double-stranded RNA-and self-RNA-induced in flammatory responses by upregulating TLR3 and melanoma differentiation-associated gene5.J Immunol, 0,5(2):1 283-294.

[22] Bonilla WV, Frohlich A, Senn K, et al.The alarmin interleukin-33 drives protective antiviral CD8＋ T cell responses.Science, 2,5(6071):984-989.

[23] Brunner SM, Schiechl G, Fal W, et al.Interleukin-33 prolongs allograft survival during chronic cardiac rejection.TransplInt, 1,2(10)4:1 027-039.

[24] Matta BM, Lott JM, Mathews LR, et al.IL-33 is an unconventional alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2＋ regulatory T cells.J Immunol, 4,3(8):4 010-020.

[25] Mitchell RN, Libby P.Vascular remodeling in transplant vasculopathy.Circ Res, 7,0(7):967-978.

[26] Wu CJ, Lovett M, Wong-Lee J, et al.Cytokine gene expression in rejecting cardiac allografts.Transplantation, 2,4(2):326-332.

[27] Stadlbauer TH, Wagner AH, Holschermann H, et al.AP-1 and STAT-1 decoy oligodeoxynucleotides attenuate transplant vasculopathy in rat cardi敡牣琠敡湬獬楯潧湲??慴牳搮楃潡癲慤獩捯?剡敳獣??????????????????戰爵????嬾?《崊??愸牝琠??愠瑊祈愬猠????乲攠橊慓琮?卨???潡牴摨慥湰?????攠瑤?慡汴???乡?杨慷浡浹愠?慯湮摴??慢獵??慳猠??瀠慔瑎框眠慰祬獵?挠潉潆灎攭爠慧瑡敭?瑡漭?楥湤摩畡捴敥?洠敨摵業慡汮?捥敮汤汯?汨潥獬獩?慬渠摩?湪敵潲楹渮瑊椠浉慭汭?汮敯獬椬漠渵?昵漨爳洩愺琱椠漸渵?椭游?愶氮氼潢杲爾愊昊琊?瘲愹獝挠畔汥潬灬慩瑤桥祳?呇爬愠湔獥灲汥??浄流甬渠潋汩??ど?????????????????扡牬????孥??嵥??潮椭敧湡??晡猠桥慬物楣?????桲潴祥??????捥?慯湳畩獳?????敨瑥?慡汢??祮捣汥漠獯灦漠牬楥湵敫?瑣特整慥瑳洮敎湡瑴?灲牥攬猠攰爬瘳攨猶?挶漶爩漺渲愰爷礭′爱攱献椼獢瑲愾渊挊攊?愳爰瑝攠牙祵?晌甬渠捑瑩楮漠湌?椠湚?牡慮瑧?捈愬爠摥楴愠捡?愮汁汉潐朱爠慰晲瑥獶????攠慧牲瑡??甠湡杲?呥牲慩湯獳灣汬慥湲瑯??????㈠???????ど???扩牮????孥??嵮?癧潡湭?剡漭獤獥異浥?????愠桳敭牯?????桵潳祣?????浬浬甠湰敲?浬敩摦楥慲瑡整摩?癮愠獡据畤氠慩牮?楩湭橡畬爠祥?慰湡摮?摩祯獮昮畃湩捲瑣椠潒湥?椬渠?琬爹愨渴猩瀺水愱游琭?愲爷琮攼牢楲漾猊挊氊敛爳漱獝椠獈??牯潨湡瑳??洠浔甬渠潃汨????至?????????????扥爠????扴爠?l.A novel pathway of chronicallo graft rejection mediated by NK cells and alloantibody.Am J Transplant, 2,2(2):313-321.

[32] Jindra PT, Jin YP, Rozengurt E, et al.HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway.J Immunol, 8,0(4):2 357-366.

[33] Soulez M, Pilon EA, Dieude M,et al.The perlecan fragment LG3 is a novel regulator of obliterative remodeling associated with allograft vascular rejection.Circ Res, 2,0(1):94-104.

[34] 万云乐, 沈文律, 李幼平, 等.体液免疫在异品系大鼠腹主动脉移植硬化中的作用.中国病理生理杂志, 7,3(2):393-395.

[35] Hollenberg SM, Klein LW, Parrillo JE, et al.Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death.Circulation, 1,4(25):3 091-096.

[36] Koh KP, Wang Y, Yi T, et al.T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase.J Clin Invest, 4,4(6):846-856.

[37] Choy JC, Yi T, Rao DA, et al.CXCL12 induction of inducible nitric oxide synthase in human CD8 T cells.J Heart Lung Transplant, 8,7(12):1 333-339.

[38] Liu AC, Lee M, McManus BM, et al.Induction of endothelial nitric oxide synthase expression by IL-17 in human vascular endothelial cells:implications for vascular remodeling in transplant vasculopathy.J Immunol, 2,8(3):1 544-550.

[39] Nguyen H, Chiasson VL, Chatterjee P, et al.Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hyp

Get Citation

ZHAO Xiao-Xia. Research Progress on Immunopathological Mechanisms of Graft Arteriosclerosis[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2016,24(6):639-643.

Copy

Article Metrics

Abstract:997
PDF: 459
HTML: 0
Cited by: 0

History

Received:November 30,2015
Revised:February 01,2016
Adopted:
Online: June 30,2016
Published:

Policies & Instructions

Get Citation

Related Videos

Share

Article Metrics

History

Article QR Code